Live webinar! The importance of controls and novel solutions for successful real-time qPCR

Live qPCR webinar

Reverse transcription quantitative PCR (RT-qPCR) is one of the most widely used methods for gene quantification today because it offers numerous advantages. High sensitivity, accuracy, speed and specificity are the key benefits that have made it a gold standard for gene expression analysis. However, a number of critical factors are involved during the various steps of the technique, which may have a direct impact on the final results. RT-qPCR workflows that include in-process controls ensure that your data is biologically relevant by minimizing variables and monitoring accuracy.

In this live webinar, Dirk Schacht will explain the importance of controls in real-time qPCR and present data on the performance of qRT-PCR assays. He will also discuss innovative solutions for one-step and two-step RT-PCR and explain how the inclusion of internal control RNA, removal of genomic DNA, room-temperature setup capability and a built-in visual pipetting control ensure artefacts are kept to a minimum and you get reliable gene expression profiles. Join us to find out how you can verify accurate performance in qRT-PCR and improve your results!

We look forward to addressing the challenges you face in gene expression profiling using RT-qPCR.

Sign up for your preferred time:

Live webinar: The importance of controls and novel solutions for successful real-time qPCR

When: Tuesday, March 28, 9:30 a.m. EST and 3:30 p.m. CET
Join now:

When: Tuesday, March 28, 1:00 p.m. EST and 7:00 p.m. CET
Join now:

Save your spot
for the live presentation and take this opportunity to get your questions about qPCR answered by Dirk Schacht.

Sign up for the live webinar!

Vishwadeepak Tripathi

Vishwadeepak Tripathi, PhD is a Global Market Manager at QIAGEN. He received his PhD in biochemistry at the Faculty of Medicine from Ruhr-University Bochum, Germany. Dr. Tripathi studied the role of chaperones and co-chaperones in protein folding and quality control and authored a number of scientific publications. He was also at RIKEN Institute in Japan where he studied the pathogenesis of Huntington's disease in cellular and mice models. He is currently interested in biomarker research, NGS and neurodegeneration.

Your email address will not be published. Required fields are marked *